Viruses and germs lurk everywhere: on surfaces that we touch and in the air. People catch most of them by breathing them in. “Many viruses like to enter through the ...

The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.

Straight from the trenches of caring for their own babies and toddlers through cold and flu season, six pediatricians share ...

A Dayton native returns home to open the area's first clinic offering an in-office solution for nose, sinus and sleep apnea ...

Bilateral versus unilateral cases of chronic rhinosinusitis with nasal polyps have notable clinical and laboratory ...

Within a week of the exposure ending, we began 30 days of nasal administration of either NEP1-40, an NgR1 antagonist inhibiting peptide, or a scrambled peptide control. There were four groups: NEP ...

Objective: To explore the diagnosis of cerebral venous sinus stenosis(CVSS) in idiopathic intracranial hypertension(IIH)，and to evaluate the efficacy and risk of ...

Some rates use different ages or coverage limits. Travelers and State Farm offer the best combination of dependable customer service and cheap rates in Connecticut. Both companies offer online quotes, ...

Currently, sinus CT is an essential non-invasive tool for preoperative assessment of CRSwNP endotypes, and formulation of personalized and precise treatment strategies. It provides otolaryngologists ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...